CD4 and endometrial cancer: We have previously focused on antitumor immunity in the microenvironment of endometrial cancer, and reported that high density of CD4+ tumor-infiltrating immune cells (TICs) was a significant and independent prognostic factor for favorable overall survival in endometrial cancers [20].